Search Results 1141-1150 of 21719 for Inhibition

1. A Study To Assess Adverse Events And Change In Disease Activity In Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone Or With Standard Of Care In Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer And No Radiographic Evidence Of Disease - Mayo Clinic

   * Must have received at least 3 months of platinum-based doublet adjuvant chemotherapy but may not have been treated with topoisomerase inhibitors as part of ...

2. A Study of Copanlisib and Nivolumab in Treating Participants With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell Lymphoma - Mayo Clinic

   Patients should be excluded if they have had prior treatment with a Pi3 kinase inhibitor, anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any ...

3. GEN1046 in Combination With Anticancer Agents for the Treatment of Advanced Endometrial Cancer - Mayo Clinic

   for or intolerant to platinum. - Cohort A only: Must be treatment naive for CPIs including PD-1 or PD-L1 inhibitors and ... PD-1/PD-L1 inhibitor alone or in ...

4. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

   Eligible for cytotoxic chemotherapy. · Prior systemic therapy for this type of sarcoma. · Prior treatment with any VEGFR tyrosine kinase inhibitor.

5. An Observational Study of Patients with Primary Hyperoxaluria Type 1 - Mayo Clinic

   as vitamin B-6, crystal inhibitors such as citrate or phosphate, or medications. used for the treatment of acute stone episodes such as tamsulosin are ...

6. Thyroid peroxidase antibody test: What is it? - Mayo Clinic

   Pain and depression: Is there a link? Selective serotonin reuptake inhibitors (SSRIs) · Serotonin and norepinephrine reuptake inhibitors (SNRIs) · Soy: Does it ...

7. A Study Using Avelumab in Non-Small Cell Lung Cancer that has Progressed - Mayo Clinic

   ... inhibitor (TKI) given before or after treatment with a platinum-based combination chemotherapy as defined above; Subjects with a tumor that harbors an ...

8. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

   ... inhibitors are prohibited =< 7 days prior to registration; Receiving any medications or substances that are inducers of CYP3A4; use of inducers are ...

9. Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations - Mayo Clinic

   Known allergy or hypersensitivity to phosphatidylinositol 3 kinase (PI3K) inhibitors or any component of the formulations used in this study. Cytotoxic ...

10. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer - Mayo Clinic

    Patients must not have prior exposure to mTOR inhibitors (rapamycin, everolimus, temsirolimus, deforolimus); Patients must not have prior treatment with any ...